Next-generation impactor for the pharmaceutical industry NGI Plus

for aerodynamic particle size distribution

The Next Generation Impactor NGI+ is ideal for testing all variations of inhalation solutions, offering enhanced corrosion resistance, chemical and biological durability, and a longer lifespan, ideal for a wider range of inhalation applications. Product Details The Next Generation Impactor NGI+ is perfect for testing nebulizer solutions, especially with biologics. Its enhanced materials withstand corrosive saline mixtures, making it ideal for testing inhalation therapies suited for patients with restricted breathing capacities. Cleaning impactors is crucial for preventing cross-contamination and ensuring consistent results. The NGI+ supports automated, robust cleaning methods using harsher chemicals, saving time and extending the equipment’s life. Applications Nebulizer testing Dry powder inhaler (DPI) testing Metered dose inhaler (MDI) testing Soft mist inhaler (SMI) testing Biologics and protein-based drug delivery testing Corrosive solution testing Inhalation drug development and research Features and Benefits Design based on the industry proven NGI Precise cut points 8-stage collection (7 stage + MOC) Planar arrangement with cover, cup tray and quick clamp cam Suite of accessories to make testing even more efficient Suite of accessories for additional testing (stage bypass, morphological analysis, rNGI) Enhanced corrosion and chemical resistance Extended equipment life Allows for a more robust and/or automated cleaning process for cups, nozzles, and seal body Comprised of inert materials to maintain aerosol performance